At JP Morgan, Cepheid, Gen-Probe, BD Tout Automated Instruments, Expanding Test Menus | GenomeWeb

By Bernadette Toner

Becton Dickinson, Gen-Probe, and Cepheid last week updated attendees of an investor conference on their development timelines for upcoming nucleic acid testing platforms and assays.

Speaking at the JP Morgan Healthcare Conference in San Francisco, the tool vendors emphasized their plans to launch automated testing platforms intended to reduce the time and complexity of nucleic acid-based molecular diagnostic testing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.